[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "855 508 3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 51, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 929410, "exercisedValue": 0, "unexercisedValue": 249075}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 46, "title": "President & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 746750, "exercisedValue": 0, "unexercisedValue": 1035052}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 651036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D.", "age": 49, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Effie  Albanis M.D.", "title": "Senior Vice President of Early Clinical & Translational Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 21.46, "open": 22.25, "dayLow": 21.0, "dayHigh": 22.25, "regularMarketPreviousClose": 21.46, "regularMarketOpen": 22.25, "regularMarketDayLow": 21.0, "regularMarketDayHigh": 22.25, "payoutRatio": 0.0, "forwardPE": -4.573276, "volume": 63437, "regularMarketVolume": 63437, "averageVolume": 190618, "averageVolume10days": 107640, "averageDailyVolume10Day": 107640, "bid": 20.88, "ask": 21.56, "bidSize": 1, "askSize": 1, "marketCap": 302641760, "fiftyTwoWeekLow": 6.875, "fiftyTwoWeekHigh": 74.49, "priceToSalesTrailing12Months": 327.18027, "fiftyDayAverage": 20.281, "twoHundredDayAverage": 21.760426, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 21746040, "profitMargins": 0.0, "floatShares": 3352584, "sharesOutstanding": 14262100, "sharesShort": 2553365, "sharesShortPriorMonth": 2245516, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.17899999, "heldPercentInsiders": 0.09279, "heldPercentInstitutions": 1.16096, "shortRatio": 11.13, "shortPercentOfFloat": 0.22719999, "impliedSharesOutstanding": 14262100, "bookValue": 19.545, "priceToBook": 1.0856997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -80870000, "trailingEps": -4.36, "forwardEps": -4.64, "lastSplitFactor": "1:4", "lastSplitDate": 1702944000, "enterpriseToRevenue": 23.509, "enterpriseToEbitda": -0.251, "52WeekChange": -0.38137794, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 21.22, "targetHighPrice": 72.0, "targetLowPrice": 26.0, "targetMeanPrice": 47.8, "targetMedianPrice": 46.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 292601984, "totalCashPerShare": 20.516, "ebitda": -86552000, "totalDebt": 11707000, "quickRatio": 20.803, "currentRatio": 21.03, "totalRevenue": 925000, "debtToEquity": 4.012, "revenuePerShare": 0.05, "returnOnAssets": -0.21966, "returnOnEquity": -0.34965, "grossProfits": -64202000, "freeCashflow": -40390876, "operatingCashflow": -69727000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -97.011894, "financialCurrency": "USD", "symbol": "NGNE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "postMarketTime": 1754694188, "regularMarketTime": 1754683200, "exchange": "NGM", "messageBoardId": "finmb_602062523", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketPrice": 21.22, "epsTrailingTwelveMonths": -4.36, "epsForward": -4.64, "epsCurrentYear": -4.37, "priceEpsCurrentYear": -4.8558354, "fiftyDayAverageChange": 0.9389992, "fiftyDayAverageChangePercent": 0.04629945, "twoHundredDayAverageChange": -0.54042625, "twoHundredDayAverageChangePercent": -0.02483528, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394202600000, "postMarketChangePercent": 1.74364, "postMarketPrice": 21.59, "postMarketChange": 0.370001, "regularMarketChange": -0.24, "regularMarketDayRange": "21.0 - 22.25", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 190618, "fiftyTwoWeekLowChange": 14.344999, "fiftyTwoWeekLowChangePercent": 2.0865455, "fiftyTwoWeekRange": "6.875 - 74.49", "fiftyTwoWeekHighChange": -53.269997, "fiftyTwoWeekHighChangePercent": -0.7151295, "fiftyTwoWeekChangePercent": -38.137794, "earningsTimestamp": 1746790200, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755201600, "isEarningsDateEstimate": true, "marketState": "CLOSED", "regularMarketChangePercent": -1.11836, "displayName": "Neurogene", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]